{"created_at":"Thu Dec 04 20:48:09 +0000 2014","id":540608519234682880,"id_str":"540608519234682880","text":"RT @FierceBiotech: ICYMI: ASH Preview: $CELG, $AMGN, PD-1, CD-38, $AGIO, $EPZM and more - http:\/\/t.co\/aNGaxCW3qM by @StacyALawrence @ASH_he\u2026","source":"\u003ca href=\"http:\/\/twitter.com\/download\/android\" rel=\"nofollow\"\u003eTwitter for Android\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":536612095,"id_str":"536612095","name":"Laura Jamieson","screen_name":"Pinckneyxx65","location":"","url":null,"description":null,"protected":false,"verified":false,"followers_count":23,"friends_count":46,"listed_count":0,"favourites_count":1089,"statuses_count":550,"created_at":"Sun Mar 25 20:15:39 +0000 2012","utc_offset":null,"time_zone":null,"geo_enabled":true,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"C0DEED","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_tile":false,"profile_link_color":"0084B4","profile_sidebar_border_color":"C0DEED","profile_sidebar_fill_color":"DDEEF6","profile_text_color":"333333","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/378800000390389036\/f16a0e60c9f8852930f8e58f9c17bd8c_normal.jpeg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/378800000390389036\/f16a0e60c9f8852930f8e58f9c17bd8c_normal.jpeg","default_profile":true,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweeted_status":{"created_at":"Thu Dec 04 19:18:17 +0000 2014","id":540585901186093057,"id_str":"540585901186093057","text":"ICYMI: ASH Preview: $CELG, $AMGN, PD-1, CD-38, $AGIO, $EPZM and more - http:\/\/t.co\/aNGaxCW3qM by @StacyALawrence @ASH_hematology","source":"\u003ca href=\"https:\/\/about.twitter.com\/products\/tweetdeck\" rel=\"nofollow\"\u003eTweetDeck\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":18294197,"id_str":"18294197","name":"FierceBiotech","screen_name":"FierceBiotech","location":"Washington, DC","url":"http:\/\/FierceBiotech.com","description":"Tweets by the Fierce Life Sciences editorial team. Subscribe to our daily email newsletter at http:\/\/www.fiercebiotech.com\/offer\/signup","protected":false,"verified":false,"followers_count":36254,"friends_count":466,"listed_count":1178,"favourites_count":7,"statuses_count":15085,"created_at":"Sun Dec 21 22:21:58 +0000 2008","utc_offset":-18000,"time_zone":"Eastern Time (US & Canada)","geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"15184C","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_tile":false,"profile_link_color":"DB5E1F","profile_sidebar_border_color":"FFFFFF","profile_sidebar_fill_color":"EBEFC3","profile_text_color":"333333","profile_use_background_image":false,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/2579189363\/5zktggp40a8nfj341ed2_normal.jpeg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/2579189363\/5zktggp40a8nfj341ed2_normal.jpeg","default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":1,"favorite_count":2,"entities":{"hashtags":[],"trends":[],"urls":[{"url":"http:\/\/t.co\/aNGaxCW3qM","expanded_url":"http:\/\/www.fiercebiotech.com\/special-reports\/ash-preview-celgene-amgen-pd-1-cd-38-agios-epizyme-and-more","display_url":"fiercebiotech.com\/special-report\u2026","indices":[71,93]}],"user_mentions":[{"screen_name":"StacyALawrence","name":"Stacy Lawrence","id":523460275,"id_str":"523460275","indices":[97,112]},{"screen_name":"ASH_hematology","name":"ASH","id":84072624,"id_str":"84072624","indices":[113,128]}],"symbols":[{"text":"CELG","indices":[20,25]},{"text":"AMGN","indices":[27,32]},{"text":"AGIO","indices":[47,52]},{"text":"EPZM","indices":[54,59]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"low","lang":"sk"},"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[],"trends":[],"urls":[{"url":"http:\/\/t.co\/aNGaxCW3qM","expanded_url":"http:\/\/www.fiercebiotech.com\/special-reports\/ash-preview-celgene-amgen-pd-1-cd-38-agios-epizyme-and-more","display_url":"fiercebiotech.com\/special-report\u2026","indices":[90,112]}],"user_mentions":[{"screen_name":"FierceBiotech","name":"FierceBiotech","id":18294197,"id_str":"18294197","indices":[3,17]},{"screen_name":"StacyALawrence","name":"Stacy Lawrence","id":523460275,"id_str":"523460275","indices":[116,131]},{"screen_name":"ASH_hematology","name":"ASH","id":84072624,"id_str":"84072624","indices":[132,140]}],"symbols":[{"text":"CELG","indices":[39,44]},{"text":"AMGN","indices":[46,51]},{"text":"AGIO","indices":[66,71]},{"text":"EPZM","indices":[73,78]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"medium","lang":"sk","timestamp_ms":"1417726089663"}
